(RZLV) Rezolve AI Ordinary Shares - NASDAQ

Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 1.085m USD | Total Return: -18.3% in 12m

Generative AI, Retail, E-commerce, Enterprise
Total Rating 11
Safety 25
Buy Signal -0.67
Software - Infrastructure
Industry Rotation: -18.2
Market Cap: 1.08B
Avg Turnover: 36.4M
Risk 3d forecast
Volatility63.8%
VaR 5th Pctl9.62%
VaR vs Median-8.09%
Reward TTM
Sharpe Ratio0.32
Rel. Str. IBD8.9
Rel. Str. Peer Group37.8
Character TTM
Beta0.657
Beta Downside-1.221
Hurst Exponent0.427
Drawdowns 3y
Max DD91.85%
CAGR/Max DD-0.42
CAGR/Mean DD-0.81

Warnings

Share dilution 60.0% YoY

Interest Coverage Ratio -42.2 is critical

Beneish M-Score 1.00 > -1.5 - likely earnings manipulation

Altman Z'' -5.29 < 1.0 - financial distress zone

Volatile

Tailwinds

No distinct edge detected

Description: RZLV Rezolve AI Ordinary Shares

Rezolve AI PLC (NASDAQ: RZLV) is a London-based software company that provides generative AI solutions targeted at the retail and e-commerce sectors, operating primarily in the United Kingdom and the United States. Its customer base spans retailers, brands, manufacturers, banks, and other enterprise clients. The company was founded in 2016, completed its IPO on NASDAQ in August 2024, and rebranded from Rezolve AI Limited to Rezolve AI PLC in March 2025.

Within the application software segment of the information technology sector, Rezolve AI operates in the enterprise AI category, selling its offerings through a B2B software model to large commercial customers. The company is classified as a small-cap stock with a market capitalization of approximately $1.1 billion USD.

Headlines to Watch Out For
  • Microsoft Azure partnership expands enterprise AI distribution
  • Retail and e-commerce platform adoption drives ARR growth
  • Competition from Salesforce and Shopify pressures pricing and margins
Piotroski VR-10 (Strict) 0.0
Net Income: -159.3m TTM > 0 and > 6% of Revenue
FCF/TA: -0.17 > 0.02 and ΔFCF/TA 69.77 > 1.0
NWC/Revenue: -164.0% < 20% (prev -23.8k%; Δ 23.7k% < -1%)
CFO/TA -0.12 > 3% & CFO -73.1m > Net Income -159.3m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 0.67 > 1.5 & < 3
Outstanding Shares: last quarter (333.3m) vs 12m ago 60.04% < -2%
Gross Margin: 69.50% > 18% (prev 81.87%; Δ -12.36% > 0.5%)
Asset Turnover: 16.82% > 50% (prev 0.95%; Δ 15.87% > 0%)
Interest Coverage Ratio: -42.21 > 6 (EBIT TTM -148.1m / Interest Expense TTM 3.51m)
Altman Z'' -5.29
A: -0.14 (Total Current Assets 175.0m - Total Current Liabilities 262.1m) / Total Assets 611.7m
B: -0.59 (Retained Earnings -359.6m / Total Assets 611.7m)
C: -0.47 (EBIT TTM -148.1m / Avg Total Assets 315.8m)
D: 0.68 (Book Value of Equity 246.8m / Total Liabilities 364.9m)
Altman-Z'' = -5.29 = D
Beneish M 1.00
DSRI: 0.21 (Receivables 44.8m/745k, Revenue 53.1m/188k)
GMI: 1.18 (GM 81.87% / 69.50%)
AQI: 2.08 (AQ_t 0.71 / AQ_t-1 0.34)
SGI: 282.9 (Revenue 53.1m / 188k)
TATA: -0.14 (NI -159.3m - CFO -73.1m) / TA 611.7m)
Beneish M = 199.2 (Cap -4..+1) = D
What is the price of RZLV shares?

As of June 27, 2026, the stock is trading at USD 2.41 with a total of 34,232,199 shares traded. Over the past week, the price has changed by -11.40%, over one month by -7.31%, over three months by +2.55% and over the past year by -18.31%.

Current recommended Stop Loss: 2.10 (which is 12.9% or 1.7 ATR below the current price).

Is RZLV a buy, sell or hold?

Rezolve AI Ordinary Shares has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy RZLV.

  • StrongBuy: 2
  • Buy: 3
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the RZLV price?
Analysts Target Price 10.8 346.1%
Rezolve AI Ordinary Shares (RZLV) - Fundamental Data Overview as of 23 June 2026
Market Cap USD = 1.08b (1.08b USD * 1.0 USD.USD)
P/S = 23.1797
P/B = 4.3791
Revenue TTM = 53.1m USD
EBIT TTM = -148.1m USD
EBITDA TTM = -139.5m USD
Long Term Debt = 50.1m USD (from longTermDebt, last quarter)
Short Term Debt = 106.4m USD (from shortTermDebt, last quarter)
Debt = 160.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 2.80m
Net Debt = 49.0m USD (calculated: Debt 160.1m - CCE 111.1m)
Enterprise Value = 1.13b USD (1.08b + Debt 160.1m - CCE 111.1m)
Interest Coverage Ratio = -42.21 (Ebit TTM -148.1m / Interest Expense TTM 3.51m)
EV/FCF = -10.60x (Enterprise Value 1.13b / FCF TTM -107.0m)
FCF Yield = -9.44% (FCF TTM -107.0m / Enterprise Value 1.13b)
 FCF Margin = -201.4% (FCF TTM -107.0m / Revenue TTM 53.1m)
 Net Margin = -299.8% (Net Income TTM -159.3m / Revenue TTM 53.1m)
 Gross Margin = 69.50% ((Revenue TTM 53.1m - Cost of Revenue TTM 16.2m) / Revenue TTM)
Gross Margin QoQ = 61.35% (prev none%)
Tobins Q-Ratio = 1.85 (Enterprise Value 1.13b / Total Assets 611.7m)
Interest Expense / Debt = 2.19% (Interest Expense 3.51m / Debt 160.1m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -117.0m (EBIT -148.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.67 (Total Current Assets 175.0m / Total Current Liabilities 262.1m)
Debt / Equity = 0.65 (Debt 160.1m / totalStockholderEquity, last quarter 246.8m)
 Debt / EBITDA = -0.35 (negative EBITDA) (Net Debt 49.0m / EBITDA -139.5m)
 Debt / FCF = -0.46 (negative FCF - burning cash) (Net Debt 49.0m / FCF TTM -107.0m)
 Total Stockholder Equity = 51.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -50.44% (Net Income -159.3m / Total Assets 611.7m)
RoE = -312.4% (Net Income TTM -159.3m / Total Stockholder Equity 51.0m)
 RoCE = -146.5% (out of range, set to none) (EBIT -148.1m / Capital Employed (Equity 51.0m + L.T.Debt 50.1m))
 RoIC = -25.80% (negative operating profit) (NOPAT -117.0m / Invested Capital 453.4m)
 WACC = 7.45% (E(1.08b)/V(1.24b) * Re(8.29%) + D(160.1m)/V(1.24b) * Rd(2.19%) * (1-Tc(0.21)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 35.81 | Cagr: 422.6%
 [DCF] Fair Price = unknown (Cash Flow -107.0m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 99.87 | Revenue CAGR: 1.70k% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=-0.20 | Chg30d=+0.00% | Revisions=-33% | GrowthEPS=+48.4% | GrowthRev=+661.8%
EPS next Year (2027-12-31): EPS=-0.12 | Chg30d=+0.00% | Revisions=N/A | GrowthEPS=+40.1% | GrowthRev=+52.5%
[Analyst] Revisions Ratio: -33%